APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Single Cell RNA Sequencing Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Single Cell RNA Sequencing Service Market Outlook and Growth Opportunities 2026

Report ID 17424129045 June 2026216 pages

Choose your research edition.

Industry ResearchSingle Cell RNA Sequencing Service Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Single Cell RNA Sequencing Service Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Single Cell RNA Sequencing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Single Cell RNA Sequencing Service Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Single Cell RNA Sequencing Service Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Single Cell RNA Sequencing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Single Cell RNA Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Single Cell RNA Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Single Cell RNA Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Single Cell RNA Sequencing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Single Cell RNA Sequencing Service market include BD, Admera Health, Novogene, BGI, SingleronBio, Active Motif, Thunder Bio, 10k Genomics and IQVIA Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Single Cell RNA Sequencing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Single Cell RNA Sequencing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Single Cell RNA Sequencing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Single Cell RNA Sequencing Service market.

Single Cell RNA Sequencing Service Segment by Company

BD

Admera Health

Novogene

BGI

SingleronBio

Active Motif

Thunder Bio

10k Genomics

IQVIA Laboratories

Biomarker

Oxford Nanopore Technologies

M20 Genomics

Illumina

QIAGEN

Q2 Solutions

Novogene

Mission bio

PacBio

Azenta Life Sciences

Jingxin Biological

TaKaRa

Bio-Rad

Single Cell RNA Sequencing Service Segment by Type

Single-cell Transcriptome Sequencing

Single-cell Nuclear Transcriptome Sequencing

Single Cell RNA Sequencing Service Segment by Application

Cancer

Immunology

Neurology

Other

Single Cell RNA Sequencing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Single Cell RNA Sequencing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Single Cell RNA Sequencing Service key companies, revenue, market share, and recent developments.

3. To split the Single Cell RNA Sequencing Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Single Cell RNA Sequencing Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Single Cell RNA Sequencing Service significant trends, drivers, influence factors in global and regions.

6. To analyze Single Cell RNA Sequencing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Single Cell RNA Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Single Cell RNA Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Single Cell RNA Sequencing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Single Cell RNA Sequencing Service industry.

Chapter 3: Detailed analysis of Single Cell RNA Sequencing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Single Cell RNA Sequencing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Single Cell RNA Sequencing Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Single Cell RNA Sequencing Service Industry Trends Table 2. Single Cell RNA Sequencing Service Industry Drivers Table 3. Single Cell RNA Sequencing Service Industry Opportunities and Challenges Table 4. Single Cell RNA Sequencing Service Industry Restraints Table 5. Global Single Cell RNA Sequencing Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Single Cell RNA Sequencing Service Revenue Share by Company (2021-2026) Table 7. Global Single Cell RNA Sequencing Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Single Cell RNA Sequencing Service Key Company Manufacturing Base & Headquarters Table 9. Global Single Cell RNA Sequencing Service Company, Product Type & Application Table 10. Global Single Cell RNA Sequencing Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Single Cell RNA Sequencing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Single-cell Transcriptome Sequencing Table 15. Significant Companies of Single-cell Nuclear Transcriptome Sequencing Table 16. Global Single Cell RNA Sequencing Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Single Cell RNA Sequencing Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Single Cell RNA Sequencing Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Single Cell RNA Sequencing Service Sales Value Share by Type (2021-2026) Table 20. Global Single Cell RNA Sequencing Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Cancer Table 22. Significant Companies of Immunology Table 23. Significant Companies of Neurology Table 24. Significant Companies of Other Table 25. Global Single Cell RNA Sequencing Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Single Cell RNA Sequencing Service Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Single Cell RNA Sequencing Service Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Single Cell RNA Sequencing Service Sales Value Share by Application (2021-2026) Table 29. Global Single Cell RNA Sequencing Service Sales Value Share by Application (2027-2032) Table 30. Global Single Cell RNA Sequencing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Single Cell RNA Sequencing Service Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Single Cell RNA Sequencing Service Sales Value Share by Region (2021-2026) Table 33. Global Single Cell RNA Sequencing Service Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Single Cell RNA Sequencing Service Sales Value Share by Region (2027-2032) Table 35. Global Single Cell RNA Sequencing Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Single Cell RNA Sequencing Service Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Single Cell RNA Sequencing Service Sales Value Market Share by Country (2021-2026) Table 38. Global Single Cell RNA Sequencing Service Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Single Cell RNA Sequencing Service Sales Value Market Share by Country (2027-2032) Table 40. BD Company Information Table 41. BD Business Overview Table 42. BD Single Cell RNA Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. BD Single Cell RNA Sequencing Service Product Portfolio Table 44. BD Recent Development Table 45. Admera Health Company Information Table 46. Admera Health Business Overview Table 47. Admera Health Single Cell RNA Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Admera Health Single Cell RNA Sequencing Service Product Portfolio Table 49. Admera Health Recent Development Table 50. Novogene Company Information Table 51. Novogene Business Overview Table 52. Novogene Single Cell RNA Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Novogene Single Cell RNA Sequencing Service Product Portfolio Table 54. Novogene Recent Development Table 55. BGI Company Information Table 56. BGI Business Overview Table 57. BGI Single Cell RNA Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. BGI Single Cell RNA Sequencing Service Product Portfolio Table 59. BGI Recent Development Table 60. SingleronBio Company Information Table 61. SingleronBio Business Overview Table 62. SingleronBio Single Cell RNA Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. SingleronBio Single Cell RNA Sequencing Service Product Portfolio Table 64. SingleronBio Recent Development Table 65. Active Motif Company Information Table 66. Active Motif Business Overview Table 67. Active Motif Single Cell RNA Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Active Motif Single Cell RNA Sequencing Service Product Portfolio Table 69. Active Motif Recent Development Table 70. Thunder Bio Company Information Table 71. Thunder Bio Business Overview Table 72. Thunder Bio Single Cell RNA Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Thunder Bio Single Cell RNA Sequencing Service Product Portfolio Table 74. Thunder Bio Recent Development Table 75. 10k Genomics Company Information Table 76. 10k Genomics Business Overview Table 77. 10k Genomics Single Cell RNA Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. 10k Genomics Single Cell RNA Sequencing Service Product Portfolio Table 79. 10k Genomics Recent Development Table 80. IQVIA Laboratories Company Information Table 81. IQVIA Laboratories Business Overview Table 82. IQVIA Laboratories Single Cell RNA Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. IQVIA Laboratories Single Cell RNA Sequencing Service Product Portfolio Table 84. IQVIA Laboratories Recent Development Table 85. Biomarker Company Information Table 86. Biomarker Business Overview Table 87. Biomarker Single Cell RNA Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Biomarker Single Cell RNA Sequencing Service Product Portfolio Table 89. Biomarker Recent Development Table 90. Oxford Nanopore Technologies Company Information Table 91. Oxford Nanopore Technologies Business Overview Table 92. Oxford Nanopore Technologies Single Cell RNA Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Oxford Nanopore Technologies Single Cell RNA Sequencing Service Product Portfolio Table 94. Oxford Nanopore Technologies Recent Development Table 95. M20 Genomics Company Information Table 96. M20 Genomics Business Overview Table 97. M20 Genomics Single Cell RNA Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. M20 Genomics Single Cell RNA Sequencing Service Product Portfolio Table 99. M20 Genomics Recent Development Table 100. Illumina Company Information Table 101. Illumina Business Overview Table 102. Illumina Single Cell RNA Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Illumina Single Cell RNA Sequencing Service Product Portfolio Table 104. Illumina Recent Development Table 105. QIAGEN Company Information Table 106. QIAGEN Business Overview Table 107. QIAGEN Single Cell RNA Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. QIAGEN Single Cell RNA Sequencing Service Product Portfolio Table 109. QIAGEN Recent Development Table 110. Q2 Solutions Company Information Table 111. Q2 Solutions Business Overview Table 112. Q2 Solutions Single Cell RNA Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Q2 Solutions Single Cell RNA Sequencing Service Product Portfolio Table 114. Q2 Solutions Recent Development Table 115. Novogene Company Information Table 116. Novogene Business Overview Table 117. Novogene Single Cell RNA Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Novogene Single Cell RNA Sequencing Service Product Portfolio Table 119. Novogene Recent Development Table 120. Mission bio Company Information Table 121. Mission bio Business Overview Table 122. Mission bio Single Cell RNA Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Mission bio Single Cell RNA Sequencing Service Product Portfolio Table 124. Mission bio Recent Development Table 125. PacBio Company Information Table 126. PacBio Business Overview Table 127. PacBio Single Cell RNA Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. PacBio Single Cell RNA Sequencing Service Product Portfolio Table 129. PacBio Recent Development Table 130. Azenta Life Sciences Company Information Table 131. Azenta Life Sciences Business Overview Table 132. Azenta Life Sciences Single Cell RNA Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Azenta Life Sciences Single Cell RNA Sequencing Service Product Portfolio Table 134. Azenta Life Sciences Recent Development Table 135. Jingxin Biological Company Information Table 136. Jingxin Biological Business Overview Table 137. Jingxin Biological Single Cell RNA Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Jingxin Biological Single Cell RNA Sequencing Service Product Portfolio Table 139. Jingxin Biological Recent Development Table 140. TaKaRa Company Information Table 141. TaKaRa Business Overview Table 142. TaKaRa Single Cell RNA Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. TaKaRa Single Cell RNA Sequencing Service Product Portfolio Table 144. TaKaRa Recent Development Table 145. Bio-Rad Company Information Table 146. Bio-Rad Business Overview Table 147. Bio-Rad Single Cell RNA Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. Bio-Rad Single Cell RNA Sequencing Service Product Portfolio Table 149. Bio-Rad Recent Development Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Single Cell RNA Sequencing Service Product Image Figure 2. Global Single Cell RNA Sequencing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Single Cell RNA Sequencing Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Single Cell RNA Sequencing Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Single-cell Transcriptome Sequencing Image Figure 8. Single-cell Nuclear Transcriptome Sequencing Image Figure 9. Global Single Cell RNA Sequencing Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Single Cell RNA Sequencing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Single Cell RNA Sequencing Service Sales Value Share by Type (2021-2032) Figure 12. Cancer Image Figure 13. Immunology Image Figure 14. Neurology Image Figure 15. Other Image Figure 16. Global Single Cell RNA Sequencing Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Single Cell RNA Sequencing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Single Cell RNA Sequencing Service Sales Value Share by Application (2021-2032) Figure 19. Global Single Cell RNA Sequencing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Single Cell RNA Sequencing Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Single Cell RNA Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 22. North America Single Cell RNA Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Single Cell RNA Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Single Cell RNA Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Single Cell RNA Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Single Cell RNA Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Single Cell RNA Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 28. South America Single Cell RNA Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Single Cell RNA Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Single Cell RNA Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Single-cell Transcriptome Sequencing
  • Single-cell Nuclear Transcriptome Sequencing
Applications
  • Cancer
  • Immunology
  • Neurology
  • Other
Companies covered
  • BD
  • Admera Health
  • Novogene
  • BGI
  • SingleronBio
  • Active Motif
  • Thunder Bio
  • 10k Genomics
  • IQVIA Laboratories
  • Biomarker
  • Oxford Nanopore Technologies
  • M20 Genomics
  • Illumina
  • QIAGEN
  • Q2 Solutions
  • Novogene
  • Mission bio
  • PacBio
  • Azenta Life Sciences
  • Jingxin Biological
  • TaKaRa
  • Bio-Rad

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Single Cell RNA Sequencing Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Single Cell RNA Sequencing Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Single Cell RNA Sequencing Service Market Dynamics
  1. 2.1 Single Cell RNA Sequencing Service Industry Trends
  2. 2.2 Single Cell RNA Sequencing Service Industry Drivers
  3. 2.3 Single Cell RNA Sequencing Service Industry Opportunities and Challenges
  4. 2.4 Single Cell RNA Sequencing Service Industry Restraints
3 Single Cell RNA Sequencing Service Market by Company
  1. 3.1 Global Single Cell RNA Sequencing Service Company Revenue Ranking in 2025
  2. 3.2 Global Single Cell RNA Sequencing Service Revenue by Company (2021-2026)
  3. 3.3 Global Single Cell RNA Sequencing Service Company Ranking (2024-2026)
  4. 3.4 Global Single Cell RNA Sequencing Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Single Cell RNA Sequencing Service Company Product Type and Application
  6. 3.6 Global Single Cell RNA Sequencing Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Single Cell RNA Sequencing Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Single Cell RNA Sequencing Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Single Cell RNA Sequencing Service Market by Type
  1. 4.1 Single Cell RNA Sequencing Service Type Introduction
  2. 4.1.1 Single-cell Transcriptome Sequencing
  3. 4.1.2 Single-cell Nuclear Transcriptome Sequencing
  4. 4.2 Global Single Cell RNA Sequencing Service Sales Value by Type
  5. 4.2.1 Global Single Cell RNA Sequencing Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Single Cell RNA Sequencing Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Single Cell RNA Sequencing Service Sales Value Share by Type (2021-2032)
5 Single Cell RNA Sequencing Service Market by Application
  1. 5.1 Single Cell RNA Sequencing Service Application Introduction
  2. 5.1.1 Cancer
  3. 5.1.2 Immunology
  4. 5.1.3 Neurology
  5. 5.1.4 Other
  6. 5.2 Global Single Cell RNA Sequencing Service Sales Value by Application
  7. 5.2.1 Global Single Cell RNA Sequencing Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Single Cell RNA Sequencing Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Single Cell RNA Sequencing Service Sales Value Share by Application (2021-2032)
6 Single Cell RNA Sequencing Service Regional Value Analysis
  1. 6.1 Global Single Cell RNA Sequencing Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Single Cell RNA Sequencing Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Single Cell RNA Sequencing Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Single Cell RNA Sequencing Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Single Cell RNA Sequencing Service Sales Value (2021-2032)
  7. 6.3.2 North America Single Cell RNA Sequencing Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Single Cell RNA Sequencing Service Sales Value (2021-2032)
  10. 6.4.2 Europe Single Cell RNA Sequencing Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Single Cell RNA Sequencing Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Single Cell RNA Sequencing Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Single Cell RNA Sequencing Service Sales Value (2021-2032)
  16. 6.6.2 South America Single Cell RNA Sequencing Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Single Cell RNA Sequencing Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Single Cell RNA Sequencing Service Sales Value Share by Country, 2025 VS 2032
7 Single Cell RNA Sequencing Service Country-level Value Analysis
  1. 7.1 Global Single Cell RNA Sequencing Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Single Cell RNA Sequencing Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Single Cell RNA Sequencing Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Single Cell RNA Sequencing Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Single Cell RNA Sequencing Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Single Cell RNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Single Cell RNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BD
  2. 8.1.1 BD Company Information
  3. 8.1.2 BD Business Overview
  4. 8.1.3 BD Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BD Single Cell RNA Sequencing Service Product Portfolio
  6. 8.1.5 BD Recent Developments
  7. 8.2 Admera Health
  8. 8.2.1 Admera Health Company Information
  9. 8.2.2 Admera Health Business Overview
  10. 8.2.3 Admera Health Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Admera Health Single Cell RNA Sequencing Service Product Portfolio
  12. 8.2.5 Admera Health Recent Developments
  13. 8.3 Novogene
  14. 8.3.1 Novogene Company Information
  15. 8.3.2 Novogene Business Overview
  16. 8.3.3 Novogene Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novogene Single Cell RNA Sequencing Service Product Portfolio
  18. 8.3.5 Novogene Recent Developments
  19. 8.4 BGI
  20. 8.4.1 BGI Company Information
  21. 8.4.2 BGI Business Overview
  22. 8.4.3 BGI Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BGI Single Cell RNA Sequencing Service Product Portfolio
  24. 8.4.5 BGI Recent Developments
  25. 8.5 SingleronBio
  26. 8.5.1 SingleronBio Company Information
  27. 8.5.2 SingleronBio Business Overview
  28. 8.5.3 SingleronBio Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 SingleronBio Single Cell RNA Sequencing Service Product Portfolio
  30. 8.5.5 SingleronBio Recent Developments
  31. 8.6 Active Motif
  32. 8.6.1 Active Motif Company Information
  33. 8.6.2 Active Motif Business Overview
  34. 8.6.3 Active Motif Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Active Motif Single Cell RNA Sequencing Service Product Portfolio
  36. 8.6.5 Active Motif Recent Developments
  37. 8.7 Thunder Bio
  38. 8.7.1 Thunder Bio Company Information
  39. 8.7.2 Thunder Bio Business Overview
  40. 8.7.3 Thunder Bio Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Thunder Bio Single Cell RNA Sequencing Service Product Portfolio
  42. 8.7.5 Thunder Bio Recent Developments
  43. 8.8 10k Genomics
  44. 8.8.1 10k Genomics Company Information
  45. 8.8.2 10k Genomics Business Overview
  46. 8.8.3 10k Genomics Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 10k Genomics Single Cell RNA Sequencing Service Product Portfolio
  48. 8.8.5 10k Genomics Recent Developments
  49. 8.9 IQVIA Laboratories
  50. 8.9.1 IQVIA Laboratories Company Information
  51. 8.9.2 IQVIA Laboratories Business Overview
  52. 8.9.3 IQVIA Laboratories Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 IQVIA Laboratories Single Cell RNA Sequencing Service Product Portfolio
  54. 8.9.5 IQVIA Laboratories Recent Developments
  55. 8.10 Biomarker
  56. 8.10.1 Biomarker Company Information
  57. 8.10.2 Biomarker Business Overview
  58. 8.10.3 Biomarker Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Biomarker Single Cell RNA Sequencing Service Product Portfolio
  60. 8.10.5 Biomarker Recent Developments
  61. 8.11 Oxford Nanopore Technologies
  62. 8.11.1 Oxford Nanopore Technologies Company Information
  63. 8.11.2 Oxford Nanopore Technologies Business Overview
  64. 8.11.3 Oxford Nanopore Technologies Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Oxford Nanopore Technologies Single Cell RNA Sequencing Service Product Portfolio
  66. 8.11.5 Oxford Nanopore Technologies Recent Developments
  67. 8.12 M20 Genomics
  68. 8.12.1 M20 Genomics Company Information
  69. 8.12.2 M20 Genomics Business Overview
  70. 8.12.3 M20 Genomics Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 M20 Genomics Single Cell RNA Sequencing Service Product Portfolio
  72. 8.12.5 M20 Genomics Recent Developments
  73. 8.13 Illumina
  74. 8.13.1 Illumina Company Information
  75. 8.13.2 Illumina Business Overview
  76. 8.13.3 Illumina Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Illumina Single Cell RNA Sequencing Service Product Portfolio
  78. 8.13.5 Illumina Recent Developments
  79. 8.14 QIAGEN
  80. 8.14.1 QIAGEN Company Information
  81. 8.14.2 QIAGEN Business Overview
  82. 8.14.3 QIAGEN Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 QIAGEN Single Cell RNA Sequencing Service Product Portfolio
  84. 8.14.5 QIAGEN Recent Developments
  85. 8.15 Q2 Solutions
  86. 8.15.1 Q2 Solutions Company Information
  87. 8.15.2 Q2 Solutions Business Overview
  88. 8.15.3 Q2 Solutions Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Q2 Solutions Single Cell RNA Sequencing Service Product Portfolio
  90. 8.15.5 Q2 Solutions Recent Developments
  91. 8.16 Novogene
  92. 8.16.1 Novogene Company Information
  93. 8.16.2 Novogene Business Overview
  94. 8.16.3 Novogene Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Novogene Single Cell RNA Sequencing Service Product Portfolio
  96. 8.16.5 Novogene Recent Developments
  97. 8.17 Mission bio
  98. 8.17.1 Mission bio Company Information
  99. 8.17.2 Mission bio Business Overview
  100. 8.17.3 Mission bio Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Mission bio Single Cell RNA Sequencing Service Product Portfolio
  102. 8.17.5 Mission bio Recent Developments
  103. 8.18 PacBio
  104. 8.18.1 PacBio Company Information
  105. 8.18.2 PacBio Business Overview
  106. 8.18.3 PacBio Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 PacBio Single Cell RNA Sequencing Service Product Portfolio
  108. 8.18.5 PacBio Recent Developments
  109. 8.19 Azenta Life Sciences
  110. 8.19.1 Azenta Life Sciences Company Information
  111. 8.19.2 Azenta Life Sciences Business Overview
  112. 8.19.3 Azenta Life Sciences Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Azenta Life Sciences Single Cell RNA Sequencing Service Product Portfolio
  114. 8.19.5 Azenta Life Sciences Recent Developments
  115. 8.20 Jingxin Biological
  116. 8.20.1 Jingxin Biological Company Information
  117. 8.20.2 Jingxin Biological Business Overview
  118. 8.20.3 Jingxin Biological Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Jingxin Biological Single Cell RNA Sequencing Service Product Portfolio
  120. 8.20.5 Jingxin Biological Recent Developments
  121. 8.21 TaKaRa
  122. 8.21.1 TaKaRa Company Information
  123. 8.21.2 TaKaRa Business Overview
  124. 8.21.3 TaKaRa Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 TaKaRa Single Cell RNA Sequencing Service Product Portfolio
  126. 8.21.5 TaKaRa Recent Developments
  127. 8.22 Bio-Rad
  128. 8.22.1 Bio-Rad Company Information
  129. 8.22.2 Bio-Rad Business Overview
  130. 8.22.3 Bio-Rad Single Cell RNA Sequencing Service Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Bio-Rad Single Cell RNA Sequencing Service Product Portfolio
  132. 8.22.5 Bio-Rad Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst